Transcription of Nucleic Acid Pathogen Testing - Cigna
{{id}} {{{paragraph}}}
Medical Coverage Policy Effective Date .. 9/15/2021. Next Review 1/15/2022. Coverage Policy Number .. 0530. Nucleic acid Pathogen Testing Table of Contents Related Coverage Resources Overview .. 1 Preventive Care Services Coverage General Background ..3. Medicare Coverage Determinations ..8. Coding/Billing Information ..9. References ..36. INSTRUCTIONS FOR USE. The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies.
(gonorrhea), genital herpes (herpes simplex virus [HSV] type 1 and 2), human papillomavirus (HPV), candida, syphilis and trichomoniasis (trichomonas vaginitis) may be appropriate for asymptomatic individuals with high-risk behavior (e.g., exposure to possible infected partner, high-risk conditions (e.g., pregnancy, HIV infection), or
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}